[RGLS] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
05-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 38.20%
YoY- -32.68%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 483 489 10,860 1,865 3,834 4,200 4,219 -76.45%
PBT -21,098 -21,212 -7,222 -13,016 -21,037 -14,491 -22,168 -3.24%
Tax -8 -5 4 -16 -2 -4 -1 300.50%
NP -21,090 -21,207 -7,226 -13,000 -21,035 -14,487 -22,168 -3.27%
Tax Rate - - - - - - - -
Total Cost 21,573 21,696 18,086 14,865 24,869 18,687 26,387 -12.57%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -4,366.46 -4,336.81 -66.54 -697.05 -548.64 -344.93 -525.43 310.80%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -47.95 -48.28 -16.52 -30.01 -49.42 -34.72 -56.76 -10.64%
EPS Diluted -47.95 -48.28 -16.52 -30.01 -49.42 -34.72 -56.76 -10.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.